Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 651 to 700 of 1898

TitleReference numberPublishedLast updated
Leukomed Sorbact for preventing surgical site infectionMTG55
Brain tumours (primary) and brain metastases in over 16sNG99
Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitorTA670
Self-expanding implant insertion into the intersphincteric space for faecal incontinenceIPG685
Minimally invasive radical hysterectomy for early stage cervical cancerIPG686
The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to healMTG54
Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancerTA668
The PLASMA system for transurethral resection and haemostasis of the prostateMTG53
Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinomaTA666
Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpuraTA667
PancreatitisNG104
Diabetes in pregnancy: management from preconception to the postnatal periodNG3
Eating disorders: recognition and treatmentNG69
Peripheral arterial disease: diagnosis and managementCG147
Low back pain and sciatica in over 16s: assessment and managementNG59
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemiaTA663
Liraglutide for managing overweight and obesityTA664
Upadacitinib for treating severe rheumatoid arthritisTA665
Zio XT for detecting cardiac arrhythmiasMTG52
Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancerTA660
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinomaTA661
Durvalumab in combination for untreated extensive-stage small-cell lung cancer (terminated appraisal)TA662
Drug-eluting stents for the treatment of coronary artery diseaseTA152
Guidance on the use of coronary artery stentsTA71
Siponimod for treating secondary progressive multiple sclerosisTA656
Carfilzomib for previously treated multiple myelomaTA657
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myelomaTA658
Galcanezumab for preventing migraineTA659
Swallowable gastric balloon capsule for weight lossIPG684
Acute coronary syndromesNG185
Human and animal bites: antimicrobial prescribingNG184
Testing strategies for Lynch syndrome in people with endometrial cancerDG42
Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosisIPG681
Balloon cryoablation for Barrett's oesophagusIPG682
Balloon cryoablation for squamous dysplasia of the oesophagusIPG683
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapyTA655
Volanesorsen for treating familial chylomicronaemia syndromeHST13
Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancerTA653
Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancerTA654
SEM Scanner 200 for preventing pressure ulcersMTG51
Rheumatoid arthritis in adults: managementNG100
Behaviour change: digital and mobile health interventionsNG183
Pembrolizumab with axitinib for untreated advanced renal cell carcinomaTA650
Naldemedine for treating opioid-induced constipationTA651
Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphomaTA649
Transcranial magnetic stimulation for auditory hallucinationsIPG680
Neuropathic pain in adults: pharmacological management in non-specialist settingsCG173
Insect bites and stings: antimicrobial prescribingNG182
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)TA648
Axonics sacral neuromodulation system for treating refractory overactive bladderMTG50

Results per page

  1. 10
  2. 25
  3. 50
  4. All